Insulet Corp
(NASDAQ:PODD)
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
top performing PODD trades
-25.20%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Insulet trades made by congress members.
Tina SmithSenate (D-MN) | $50K - $100K | stock | Sale (Partial) | Apr 19, 2024 | Apr 04, 2024 | Senate |
Markwayne MullinSenate (R-OK) | $1K - $15K | stock | Sale (Partial) | Jan 26, 2024 | Dec 22, 2023 | Senate |
Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Sale | Aug 13, 2023 | Jul 12, 2023 | House |
Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Purchase | May 19, 2023 | Apr 10, 2023 | House |